EUVIMEDEUVIMED entdecken
Open Access

Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCC

Jovanka Gencel-Augusto iD, Hua Li, Liam C Woerner, Nuo Tian, Ashir A Borah, Jeffrey N Myers, Patrick Ha iD, Daniel E Johnson, Jennifer R Grandis

Head & Neck · 2026-03 · 48 (3) · 863-875

DOI: 10.1002/hed.70085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, online erschienen am 30.10.2025. Verfasst von Jovanka Gencel-Augusto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco (UCSF), San Francisco, California, USA. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University of California President's Post-doctoral Fellowship Program, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinoma (HNSCC) is a major global health challenge. Inactivation of the tumor suppressor p53 is the most frequent driver event in this malignancy. p53 inactivation occurs either through TP53 mutations in human papilloma virus (HPV)‐negative cases or via HPV‐mediated p53 degradation in HPV‐positive (HPV+) cases, where most tumors retain a wild‐type (WT) TP53 allele. This underscores the critical role ofp53‐regulated processes in HNSCC pathogenesis. Clinically, HPV+ HNSCC has significantly better outcomes than HPV‐negative disease. However, approximately 10% of HPV+ HNSCC tumors harbor TP53 mutations, suggesting selective pressure to suppress p53 signaling beyond viral degradation. In this study, we demonstrate that HPV+ TP53 ‐WTHNSCC cells have residual, tumor suppressive p53 activity. Clinically, patients with HPV+ TP53 ‐WT tumors exhibit significantly better survival than those with HPV+ TP53 ‐mutantor HPV‐negative tumors. In vitro, WT p53 loss in HPV+ HNSCC cells enhances proliferation, migration, and invasion, and transcriptomic analysis confirms ongoing p53‐dependent gene regulation. HPV+ TP53 ‐WT tumors also display tumor‐suppressive gene methylation patterns, fewer chromosomal alterations, and reduced PI3K‐AKT signaling compared to TP53 ‐mutant HPV+ cases. Notably, p53 loss increases expression of the PI3K catalytic subunit p110α, suppresses the PI3K‐AKT inhibitor INPP5D , and sensitizes cells to pharmacologic PI3Kinhibition. Together, our findings challenge the prevailing view that p53 is completely inactivated in HPV+ HNSCC and reveal tumor suppressive, p53‐driven mechanisms that persist in these tumors. These insights highlight a potential role for TP53 ‐based stratification in guiding treatment decisions and suggest new therapeutic vulnerabilities in HPV+ HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsPapillomavirus InfectionsPapillomaviridaeHumansFemaleMaleMutationCell ProliferationCell Line, TumorSignal TransductionHuman Papillomavirus Viruses

Stichwörter der Autor:innen

HNSCCHPVPI3Kp53tumor suppression

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco (UCSF), San Francisco, California, USA.
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
  • UCSF School of Medicine, San Francisco, California, USA.
  • Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Jovanka Gencel-Augusto, Patrick Ha

Förderung

  • University of California President's Post-doctoral Fellowship Program
  • NIH HHS
  • NCI NIH HHS
  • Pew Charitable Trusts
  • National Institutes of Health

Zitieren

APA

Gencel-Augusto, J., Li, H., Woerner, L. C., Tian, N., Borah, A. A., Myers, J. N., Ha, P., Johnson, D. E., & Grandis, J. R. (2026). Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCC. Head & Neck, 48(3), 863-875. https://doi.org/10.1002/hed.70085

Vancouver

Gencel-Augusto J, Li H, Woerner LC, Tian N, Borah AA, Myers JN, et al. Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCC. Head & Neck. 2026;48(3):863-875. doi:10.1002/hed.70085

BibTeX
@article{GencelAugusto2026,
  author = {Gencel-Augusto, Jovanka and Li, Hua and Woerner, Liam C and Tian, Nuo and Borah, Ashir A and Myers, Jeffrey N and Ha, Patrick and Johnson, Daniel E and Grandis, Jennifer R},
  title = {Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCC},
  journal = {Head & Neck},
  year = {2026},
  volume = {48},
  number = {3},
  pages = {863--875},
  doi = {10.1002/hed.70085}
}
Kostenlos starten →